Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes

NCT05194592 is registered in ClinicalTrials.gov with Wonju Severance Christian Hospital as lead sponsor.

NCT NCT05194592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05194592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes
Lead sponsor
Wonju Severance Christian Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 7, 2022
Completion date
June 30, 2025
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

remodeling, ventricular, type2 diabetes